An exploratory analysis of EGFR expression in tumour biopsies has recently been performed by immunohistochemistry in the IDEAL 1 and 2 trials, in which formalin-fixed, paraffin-embedded sections were stained with the 2-18C9 clone antibody. This evidence concerns the gene EGFR and neoplasm.